RMFCX | TGDIX | RMFCX / TGDIX | |
Total Expense Ratio | 0.91 | 0.70 | 130% |
Annual Report Gross Expense Ratio | 0.91 | 0.77 | 118% |
Fund Existence | 23 years | 22 years | - |
Gain YTD | 9.578 | 7.138 | 134% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 2000 | 13% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 109B | 464M | 23,491% |
Annual Yield % from dividends | 1.27 | 0.73 | 173% |
Returns for 1 year | 8.23 | 5.78 | 142% |
Returns for 3 years | 31.78 | 39.69 | 80% |
Returns for 5 years | 57.17 | 64.43 | 89% |
Returns for 10 years | 76.07 | -20.04 | -380% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ORCX | 35.99 | 2.19 | +6.48% |
Defiance Daily Target 2X Long ORCL ETF | |||
ITDB | 31.50 | 0.13 | +0.40% |
iShares LifePath Target Date 2030 ETF | |||
XBI | 88.12 | 0.30 | +0.34% |
SPDR® S&P Biotech ETF | |||
BBBS | 51.17 | 0.03 | +0.06% |
BondBloxx BBB Rated 1-5 Yr Corp Bd ETF | |||
EYLD | 36.61 | 0.01 | +0.03% |
Cambria Emerging Shareholder Yield ETF |